# Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

> **NCT01881932** · NA · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 19 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer

## Interventions

- **DEVICE:** Acupuncture using Seirin® needles
- **DEVICE:** Sham Acupuncture using Park Sham placebo acupuncture device

## Key facts

- **NCT ID:** NCT01881932
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2014-06
- **Final completion:** 2015-04
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** The PI has moved to another institution, which resulted in significant changes in the study design and study title.
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01881932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01881932, "Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01881932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*